Gene Sequencing tests in Dubai & UAE

Compare available Gene Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

143

Listed price range

2,600.00–3,200.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Gene Sequencing test prices

Showing 106–120 of 143 matching tests.

Gene Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2499 PTPN11 Gene Noonan Syndrome Type 1 Genetic Test This test identifies pathogenic variants in the PTPN11 gene associated with Noonan syndrome type 1.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PTPN11 gene coding exons", "Pathogenic variants (missense, nonsense, splice-site, small indels)"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}, {"name": "Average Read Depth", "reference_range": "1000×"}] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Clinical suspicion of Noonan syndrome type 1", "Family history of Noonan syndrome", "Need for genetic confirmation for management and surveillance"] Measurement technique Confirm with laboratory Codes LOINC: 94833-5 ICD-10: Q87.1 Clinical summary This test identifies pathogenic variants in the PTPN11 gene associated with Noonan syndrome type 1.
TEST-3489 ROBO2 Gene Vesicoureteral Reflux Type 2 Genetic Test This test evaluates the ROBO2 gene for pathogenic variants associated with congenital vesicoureteral reflux type 2.	Peripheral whole blood (3–5 mL EDTA) or FTA card finger‑prick	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ROBO2 gene"] Parameters [] Preparation ["Avoid anticoagulant interference as per pre-visit instructions."] Indications ["Diagnosis of congenital vesicoureteral reflux type 2", "Familial risk counselling"] Measurement technique Confirm with laboratory Codes LOINC: 57691-9 ICD-10: Q62.7, N13.70, Z15.8 Clinical summary This test evaluates the ROBO2 gene for pathogenic variants associated with congenital vesicoureteral reflux type 2.
TEST-5557 RSPH1 Gene Primary Ciliary Dyskinesia Type 24 DNA Test (NGS) This diagnostic test evaluates the RSPH1 gene for mutations associated with Primary Ciliary Dyskinesia type 24.	Whole Blood / Extracted DNA / FTA Card (1 drop)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RSPH1 gene mutations (point mutations, indels, CNVs)"] Parameters [] Preparation ["No fasting needed", "Provide detailed clinical history", "Provide family history of PCD or situs inversus", "Provide prior genetic counselling records"] Indications ["Suspected Primary Ciliary Dyskinesia type 24", "Family history of PCD or situs inversus", "Recurrent respiratory symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 81313-7 ICD-10: J98.4 Clinical summary This diagnostic test evaluates the RSPH1 gene for mutations associated with Primary Ciliary Dyskinesia type 24.
TEST-6210 SAR1B Gene (Chylomicron Retention Disease) Genetic Test This genetic test identifies pathogenic variants in the SAR1B gene associated with chylomicron retention disease (Anderson disease).	Peripheral whole blood (or FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SAR1B gene", "SNVs, INDELs, CNVs across the full gene"] Parameters [] Preparation ["No specific fasting required", "Avoid recent blood transfusion ( Indications ["Clinical suspicion of chylomicron retention disease", "Family history of chylomicron retention disease", "Failure to thrive with fat malabsorption"] Measurement technique Confirm with laboratory Codes LOINC: 95815-3 ICD-10: E78.3 Clinical summary This genetic test identifies pathogenic variants in the SAR1B gene associated with chylomicron retention disease (Anderson disease).
TEST-4440 SCARB2 Gene Epilepsy, Progressive Myoclonic Type 4, With or Without Renal Failure Genetic Test This genetic test analyzes the SCARB2 gene to diagnose Progressive Myoclonus Epilepsy Type 4 (PME4) and assess associated kidney disease risk.	Whole blood (3–5 mL EDTA), extracted DNA, or dried blood spot on FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCARB2 gene mutations (SNVs/indels)", "Full exon coverage of SCARB2 gene"] Parameters [] Preparation ["Do not discontinue prescribed antiepileptic or renal medications without consulting your treating physician."] Indications ["Diagnosis of Progressive Myoclonus Epilepsy Type 4 (PME4)", "Evaluation of associated nephropathy risk", "Personalizing antiepileptic therapy", "Guiding renal surveillance"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G40.3, N18.9 Clinical summary This genetic test analyzes the SCARB2 gene to diagnose Progressive Myoclonus Epilepsy Type 4 (PME4) and assess associated kidney disease risk.
TEST-4635 SCN9A Gene Sequencing for Insensitivity to Pain (Channelopathy‑Associated) Test This test evaluates the SCN9A gene for mutations associated with congenital insensitivity to pain (CIP) and related channelopathies.	Peripheral Whole Blood or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCN9A gene mutations", "SNVs", "Indels", "Copy Number Variations"] Parameters [] Preparation [] Indications ["Congenital insensitivity to pain (CIP)", "Channelopathy-associated pain disorders", "Hereditary sensory neuropathies"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: G60.8 Clinical summary This test evaluates the SCN9A gene for mutations associated with congenital insensitivity to pain (CIP) and related channelopathies.
TEST-3834 SETX Gene Ataxia-Oculomotor Apraxia Type 2 Genetic Test This genetic test identifies pathogenic variants within the SETX gene, confirming a diagnosis of ataxia-oculomotor apraxia type 2 (AOA2).	Whole Blood (Lavender Top EDTA Tube) or Dried Blood Spot (DBS) Card	21–28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SETX gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation [] Indications ["Individuals presenting with progressive cerebellar ataxia, oculomotor apraxia, and/or positive family history consistent with autosomal recessive inheritance.", "Elevated serum alpha-fetoprotein (AFP) further supports clinical suspicion."] Measurement technique Confirm with laboratory Codes LOINC: 94206-2 ICD-10: G11.3 Clinical summary This genetic test identifies pathogenic variants within the SETX gene, confirming a diagnosis of ataxia-oculomotor apraxia type 2 (AOA2).
TEST-5802 SFTPC Gene Genetic Test for Surfactant Metabolism Dysfunction Type 2 This test evaluates the SFTPC gene for pathogenic variants associated with pulmonary surfactant metabolism dysfunction type 2 (SMDP2).	Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	12–15 Business Days (Standard) / 5–7 Business Days (Express)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SFTPC gene sequence", "Pathogenic variants (SNVs, Indels, CNVs)"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without physician consultation"] Indications ["Suspected pulmonary surfactant metabolism dysfunction type 2 (SMDP2)", "Interstitial lung disease of unknown origin in infants or children"] Measurement technique Confirm with laboratory Codes LOINC: 82314-5 ICD-10: J84.10, P27.8 Clinical summary This test evaluates the SFTPC gene for pathogenic variants associated with pulmonary surfactant metabolism dysfunction type 2 (SMDP2).
TEST-5064 SH3PXD2B Gene (Frank-ter Haar Syndrome) Genetic Test This genetic test identifies pathogenic variants in the SH3PXD2B gene to diagnose Frank-ter Haar syndrome.	Whole Blood (EDTA), FTA Card, or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in SH3PXD2B gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation [] Indications ["Patients presenting with symptoms suggestive of Frank-ter Haar syndrome", "Differential diagnosis clarification (e.g., Melnick-Needles syndrome, Rothmund-Thomson syndrome)", "Family history of Frank-ter Haar syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Q87.0 Clinical summary This genetic test identifies pathogenic variants in the SH3PXD2B gene to diagnose Frank-ter Haar syndrome.
TEST-3867 SHANK2 Gene (Autism Susceptibility, X-Linked Type 17) NGS Test This diagnostic test evaluates the entire coding region of the SHANK2 gene for variants associated with X-linked autism susceptibility type 17.	Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SHANK2 gene variants", "Copy Number Variations (CNV) in SHANK2"] Parameters [] Preparation [] Indications ["Suspected X-linked autism susceptibility type 17", "Diagnostic confirmation in individuals with relevant clinical features", "Family history of SHANK2-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 76067-3 ICD-10: Z15.09 Clinical summary This diagnostic test evaluates the entire coding region of the SHANK2 gene for variants associated with X-linked autism susceptibility type 17.
TEST-6027 SLC10A2 Gene Primary Bile Acid Malabsorption Genetic Test This test evaluates the SLC10A2 gene for mutations associated with primary bile acid malabsorption.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SLC10A2 gene mutations", "Genetic variants causing PBAM"] Parameters [] Preparation ["Mandatory genetic counseling session", "Provide comprehensive clinical history"] Indications ["Diagnosis of primary bile acid malabsorption", "Distinguishing PBAM from other gastrointestinal disorders"] Measurement technique Confirm with laboratory Codes LOINC: 92084-0 ICD-10: K90.4 Clinical summary This test evaluates the SLC10A2 gene for mutations associated with primary bile acid malabsorption.
TEST-3881 SLC12A3 Gene Bartter Syndrome Genetic Test This genetic test evaluates the SLC12A3 gene for pathogenic variants associated with Bartter syndrome.	Peripheral Whole Blood	21–28 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC12A3 gene", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of all current medications"] Indications ["Suspected Bartter syndrome", "Family history of Bartter syndrome", "Genetic counseling for related conditions"] Measurement technique Confirm with laboratory Codes LOINC: 101372-3 ICD-10: E26.81 Clinical summary This genetic test evaluates the SLC12A3 gene for pathogenic variants associated with Bartter syndrome.
TEST-4987 SLC27A4 Gene Ichthyosis Prematurity Syndrome Genetic Test This genetic test identifies pathogenic variants in the SLC27A4 gene associated with Ichthyosis Prematurity Syndrome (IPS). It analyzes the entire coding region via Next-Generation...	Whole blood (EDTA), extracted DNA, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC27A4 gene", "Full coding region and splice sites of the SLC27A4 gene"] Parameters [] Preparation [] Indications ["Clinical suspicion of Ichthyosis Prematurity Syndrome (IPS)", "Confirmation of clinical diagnosis", "Guidance for neonatal management", "Risk assessment for family planning", "Carrier screening in at-risk couples", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 90225-7 ICD-10: Q80.3 Clinical summary This genetic test identifies pathogenic variants in the SLC27A4 gene associated with Ichthyosis Prematurity Syndrome (IPS). It analyzes the entire coding region via Next-Generation Sequencing.
TEST-6340 SLC35A1 Gene Sequencing Test for Congenital Disorder of Glycosylation Type 2F (NGS) This test identifies pathogenic variants in the SLC35A1 gene associated with Congenital Disorder of Glycosylation Type 2F.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC35A1 gene", "Single-nucleotide variants", "Small insertions/deletions", "Splice-site mutations"] Parameters [] Preparation ["Pre-test genetic counseling session is mandatory", "Pedigree chart of family members affected by glycosylation disorder type 2F must be completed prior to sample collection", "Individuals under 18 require formal consent"] Indications ["Suspected Congenital Disorder of Glycosylation Type 2F", "Family history of glycosylation disorder type 2F"] Measurement technique Confirm with laboratory Codes LOINC: 51904-2 ICD-10: E77.8 Clinical summary This test identifies pathogenic variants in the SLC35A1 gene associated with Congenital Disorder of Glycosylation Type 2F.
TEST-6285 SLC35C1 Gene Glycosylation Disorder Type 2C Genetic Test This test evaluates the SLC35C1 gene for pathogenic variants associated with Congenital Disorder of Glycosylation Type IIc (CDG IIc). It uses Next-Generation Sequencing (NGS) to an...	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC35C1 gene", "Full coding region sequence analysis"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any anticoagulant medication use"] Indications ["Suspected diagnosis of CDG IIc based on clinical presentation", "Family history of CDG IIc", "Confirmation of genetic diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 94219-3 ICD-10: E77.8 Clinical summary This test evaluates the SLC35C1 gene for pathogenic variants associated with Congenital Disorder of Glycosylation Type IIc (CDG IIc). It uses Next-Generation Sequencing (NGS) to analyze the entire coding region of the gene.

Category overview

Gene Sequencing: overview

Achieving a definitive diagnosis for a complex or rare genetic disorder often requires reading the entire genetic code of specific genes to find elusive, hidden errors. As a cornerstone of our advanced Genetics services, Gene Sequencing expansively scans the targeted regions of your genome to uncover rare or novel mutations that standard tests miss. Utilizing state-of-the-art sequencing technology, this comprehensive molecular profiling delivers the critical data necessary to safely guide your healthcare provider in tailoring highly personalized medical management and targeted therapeutic interventions. Trusted for molecular excellence among premier diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and remarkably fast reporting. Find the clear, definitive answers you need—schedule your gene sequencing testing in UAE, coordinate a seamless clinical sample transfer, or consult our expert medical genetics professionals today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.